Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Biofrontera (BFRI) over the last 3 years, with Dec 2024 value amounting to $5.5 million.

  • Biofrontera's Shares Outstanding (Diluted Average) rose 86.64% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 86.64%. This contributed to the annual value of $5.5 million for FY2024, which is 256.74% up from last year.
  • Latest data reveals that Biofrontera reported Shares Outstanding (Diluted Average) of $5.5 million as of FY2024, which was up 256.74% from $1.5 million recorded in FY2023.
  • Biofrontera's Shares Outstanding (Diluted Average)'s 5-year high stood at $5.5 million during FY2024, with a 5-year trough of $1.1 million in FY2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $1.5 million (2023), whereas its average is $2.7 million.
  • Data for Biofrontera's Shares Outstanding (Diluted Average) shows a peak YoY surged of 256.74% (in 2024) over the last 5 years.
  • Biofrontera's Shares Outstanding (Diluted Average) (Yearly) stood at $1.1 million in 2022, then soared by 46.29% to $1.5 million in 2023, then surged by 256.74% to $5.5 million in 2024.